15 mayo 2015
An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/NJ8lvIZ_d6Y/150515111626.htm
